Top Suppliers:I want be here


256411-32-2

256411-32-2 structure
256411-32-2 structure
  • Name: Belotecan
  • Chemical Name: Camtobell
  • CAS Number: 256411-32-2
  • Molecular Formula: C25H27N3O4
  • Molecular Weight: 433.500
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2018-10-23 18:32:02
  • Modify Date: 2025-08-24 10:29:13
  • Belotecan (CKD-602 free base) is a DNA topoisomerase I inhibitor. Belotecan induces cell apoptosis and cell-cycle arrest. Belotecan is a camptothecin analogue with anti-tumor effects, it can be used for the research of cancer[1].

Name Camtobell
Synonyms Belotecan
7-(2-(N-Isopropylamino)ethyl)camptothecin
(4S)-4-Ethyl-4-hydroxy-11-[2-(isopropylamino)ethyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Belotecan [INN]
CKD602
UNII-27Z82M2G1N
(4S)-4-Ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-[2-[(1-methylethyl)amino]ethyl]-, (4S)-
Description Belotecan (CKD-602 free base) is a DNA topoisomerase I inhibitor. Belotecan induces cell apoptosis and cell-cycle arrest. Belotecan is a camptothecin analogue with anti-tumor effects, it can be used for the research of cancer[1].
Related Catalog
Target

IC50: 30 ng/mL (Caski cells), 150 ng/mL (HeLa cells), 150 ng/mL (SiHa cells)[1]

In Vitro Belotecan (0-600 ng/mL; 0-72 h) time- and dose-dependently inhibits viability of Caski cells, HeLa cells and SiHa cells at 48 h with IC50 values of 30, 150 and 150 ng/mL, respectively[1]. Belotecan (0-150 ng/mL; 48 h) induces cell apoptosis and cell-cycle arrest, and affects PARP, cleaved PARP, BAX, p53, Ser15, cell cycle related protein expression and cancer invasion in cervical cancer[1]. Apoptosis Analysis[1] Cell Line: Caski, HeLa and SiHa cell lines Concentration: 0-150 ng/mL Incubation Time: 48 h Result: Showed strong pro-apoptotic activities to Caski, HeLa and SiHa cells. Western Blot Analysis[1] Cell Line: Caski, HeLa and SiHa cell lines Concentration: 0-150 ng/mL Incubation Time: 48 h Result: Increased the expression of PARP, cleaved PARP, BAX, p53, Ser15, cyclin B1, phosphorylated cyclin B1 and phospho-cdc2 (Tyr15) protein, and decreased MMP2 and VEGF protein expression. Cell Cycle Analysis[1] Cell Line: Caski, HeLa and SiHa cell lines Concentration: 0-150 ng/mL Incubation Time: 48 h Result: Induced cell-cycle arrest in the G2/M phase in cervical cancer. Cell Invasion Assay[1] Cell Line: Caski, HeLa and SiHa cell lines Concentration: 0-150 ng/mL Incubation Time: 48 h Result: Inhibited cancer invasion in cervical cancer.
In Vivo Belotecan (25 mg/kg; i.v. for 16 days at 4-day intervals) inhibits tumor growth in CaSki-xenografts nude mice[1]. Animal Model: BALB/c-nude mice with CaSki cells injection[1] Dosage: 25 mg/kg Administration: Intravenous injection; 25 mg/kg; 16 days at 4-day intervals Result: Significantly inhibited the tumor growth and showed no significant difference in bodyweight of xenograft mice and the controls.
Density 1.4±0.1 g/cm3
Boiling Point 772.4±60.0 °C at 760 mmHg
Molecular Formula C25H27N3O4
Molecular Weight 433.500
Flash Point 420.9±32.9 °C
Exact Mass 433.200165
PSA 93.45000
LogP 1.86
Vapour Pressure 0.0±2.8 mmHg at 25°C
Index of Refraction 1.679
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.